The global vascular access device market is becoming increasingly important as healthcare systems manage rising chronic disease prevalence, growing hospitalization rates, increasing chemotherapy and dialysis procedures, and expanding demand for reliable intravenous and infusion therapy. Vascular access devices play a critical role in the administration of medications, fluids, blood products, nutrition, and other therapies, while also enabling diagnostic blood sampling across hospitals, clinics, ambulatory care settings, and other healthcare environments.

The global vascular access device market is projected to grow from USD 6.29 billion in 2026 to USD 8.70 billion by 2031, registering a CAGR of 6.7% during 2026–2031. The market was valued at approximately USD 5.94 billion in 2025. Growth is being supported by the increasing prevalence of cancer, diabetes, cardiovascular disorders, kidney disease, and other chronic conditions requiring short- or long-term vascular access. Increasing surgical volumes, hospital admissions, emergency-care requirements, and infusion-based treatments are further supporting demand. 

The market is also being transformed by advances in safety-engineered catheters, antimicrobial and antithrombogenic technologies, ultrasound-guided placement, integrated insertion systems, and catheter materials designed to improve dwell time and reduce complications. Peripheral vascular access devices are expected to be among the fastest-growing areas, while central vascular access remains important for long-term and high-acuity therapies such as chemotherapy, parenteral nutrition, and dialysis. 

Asia Pacific is expected to register the highest growth during the forecast period, supported by expanding healthcare infrastructure, increasing healthcare expenditure, rising oncology and dialysis populations, growing hospitalization rates, and broader adoption of advanced vascular access technologies in countries including China, Japan, and India. 

Against this background, the following 25 companies represent a cross-section of established global manufacturers, specialized vascular access companies, and emerging regional players contributing to innovation across peripheral, central, arterial, and intraosseous vascular access technologies.

1. Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is one of the most prominent companies in the global vascular access device market, supported by a broad portfolio spanning peripheral and central vascular access products. The company has a strong presence in hospitals and healthcare systems and focuses heavily on safety, infection prevention, catheter performance, and workflow efficiency.

BD’s vascular access portfolio includes peripheral IV catheter technologies, midline solutions, vascular access systems, and supporting technologies. Its strong global distribution network and relationships with healthcare organizations and group purchasing organizations strengthen its competitive position.

In April 2026, BD launched the BD CentroVena One Insertion System, an all-in-one central venous catheter insertion platform designed to consolidate multiple insertion components into a single system. The launch represents an important expansion of BD’s capabilities in central vascular access and demonstrates the industry’s movement toward simplified, integrated insertion workflows. 

2. Teleflex Incorporated

Teleflex is a major medical technology company with a strong position in vascular access through its Arrow portfolio. The company serves acute-care, critical-care, emergency, anesthesia, and other clinical environments requiring reliable vascular access.

Teleflex’s portfolio includes central venous catheters, peripheral access products, antimicrobial catheter technologies, pressure-injectable solutions, and intraosseous access systems. Its Arrow EZ-IO platform is particularly relevant to emergency and critical-care applications where rapid vascular access is required.

Teleflex is also expanding its broader vascular intervention capabilities through acquisitions and portfolio development. The company’s emphasis on critical-care access, procedural efficiency, and advanced catheter technologies supports its continued role in the global vascular access market. 

3. ICU Medical

ICU Medical is a major participant in infusion therapy and vascular access, with a portfolio focused on improving the safety and efficiency of intravenous treatment.

The company’s vascular access capabilities complement its broader infusion therapy portfolio, enabling hospitals to address multiple stages of medication delivery and infusion management. ICU Medical places particular emphasis on technologies that can reduce medication errors, contamination risks, and complications associated with intravenous therapy.

The integration of vascular access with infusion systems provides ICU Medical with an important competitive advantage as healthcare providers increasingly seek standardized and efficient infusion workflows.

4. Nipro

Nipro is a Japan-based healthcare company with extensive capabilities across medical devices, dialysis, infusion therapy, and vascular access.

The company’s vascular access activities benefit from its broader expertise in blood management, dialysis, and disposable medical technologies. Its presence across Asian and international healthcare markets positions Nipro to benefit from increasing demand for vascular access devices associated with chronic kidney disease, hospitalization, and infusion-based treatments.

Nipro’s established manufacturing capabilities and international reach make it an important participant in the vascular access device ecosystem. 

5. AngioDynamics, Inc.

AngioDynamics is a medical technology company focused on minimally invasive and vascular intervention technologies. Its portfolio includes products used in vascular access and related interventional procedures.

The company serves clinical applications including oncology, peripheral vascular intervention, and other minimally invasive procedures. Its expertise in catheter-based technologies gives it an important position within the broader vascular access ecosystem.

Continued innovation in catheter design and minimally invasive procedures provides opportunities for AngioDynamics as hospitals increasingly adopt less invasive treatment approaches.

6. Vygon

Vygon is a France-based medical device company specializing in technologies used in vascular access, infusion, and critical-care applications.

The company’s product portfolio includes vascular access catheters and related devices designed for neonatal, pediatric, and adult patient populations. Its specialization in clinical access technologies has helped establish Vygon as an important European participant in the market.

Vygon is particularly relevant to healthcare systems requiring specialized vascular access solutions for complex patient populations and critical-care environments.

7. Terumo Corporation

Terumo is one of the world’s major medical technology companies and has a significant presence in vascular access and interventional medicine.

The company develops technologies spanning vascular intervention, blood management, infusion, and catheter-based procedures. Its global scale and extensive healthcare relationships provide a strong platform for expanding vascular access technologies.

Terumo’s capabilities in catheter design and minimally invasive procedures position it to benefit from the industry’s emphasis on safer insertion, improved navigation, and more efficient vascular procedures.

8. Medtronic plc

Medtronic is a diversified global medical technology company with extensive capabilities in cardiovascular and minimally invasive technologies.

Its vascular and catheter-based technologies serve a broad range of clinical applications. The company’s global presence, research capabilities, and established relationships with hospitals give it access to major healthcare markets.

Medtronic’s involvement in catheter-based and vascular technologies also positions the company to participate in the continued convergence of vascular access with image-guided and minimally invasive procedures.

9. Cook Medical

Cook Medical is a major manufacturer of minimally invasive medical devices, with a broad portfolio covering vascular, interventional radiology, urology, gastroenterology, and other specialties.

The company’s vascular portfolio includes catheter-based products and access technologies used in interventional procedures. Cook’s long-standing presence in minimally invasive medicine gives it significant expertise in device design, procedural access, and catheter-based intervention.

As hospitals increasingly favor minimally invasive procedures, Cook Medical is positioned to benefit from demand for reliable access and intervention technologies.

10. B. Braun SE

B. Braun is a global healthcare company with extensive capabilities in infusion therapy, vascular access, anesthesia, surgery, and hospital care.

The company’s vascular access portfolio includes peripheral and central venous access technologies, with a strong emphasis on infection prevention, catheter safety, and clinical workflow.

B. Braun has also expanded its central venous catheter capabilities with technologies incorporating antimicrobial and antithrombogenic coatings. These innovations address major clinical concerns such as catheter-related bloodstream infections and thrombosis, particularly among high-risk patients in intensive care and oncology settings. 

11. Merit Medical Systems, Inc.

Merit Medical Systems is a diversified medical device company serving interventional, diagnostic, and therapeutic healthcare markets.

The company’s portfolio includes vascular access and catheter-based technologies designed for interventional procedures. Merit benefits from its broad relationships with hospitals and physicians and its focus on developing devices that improve procedural efficiency.

The company’s continued investment in minimally invasive technologies supports its participation in the evolving vascular access market, particularly where access devices are integrated into broader interventional workflows.

12. AMECATH

AMECATH is an Egypt-based medical device manufacturer specializing in catheter and vascular access technologies.

The company is particularly relevant to emerging markets where demand for locally manufactured medical devices is increasing alongside healthcare infrastructure development. AMECATH’s participation reflects the growing geographic diversification of the vascular access industry.

The company’s position in catheter technologies provides opportunities as hospitals and healthcare providers across developing markets expand their use of modern vascular access products.

13. Medical Components, Inc. (Medcomp)

Medical Components, Inc., commonly known as Medcomp, specializes in vascular access and dialysis-related medical devices.

The company has developed a strong position in catheter technologies used for central venous access and renal-care applications. Its expertise is particularly relevant to patients requiring long-term vascular access for dialysis and other chronic therapies.

Medcomp’s specialized focus allows it to compete in clinical applications where catheter performance, durability, and long-term access are critical.

14. Healthline Medical Products

Healthline Medical Products participates in the vascular access market through catheter and medical device technologies used in clinical settings.

The company represents the specialized manufacturer segment of the vascular access ecosystem, serving applications where reliable catheter performance and cost-effective medical devices are important.

Its presence in the market highlights the role of specialized manufacturers alongside multinational medical technology companies.

15. Access Vascular, Inc.

Access Vascular is an emerging company focused on advanced biomaterial technologies for vascular access.

The company has developed catheter technologies designed to address complications associated with conventional vascular access, particularly thrombosis and infection. Its biomaterial-based approach differentiates it from traditional catheter manufacturers.

MarketsandMarkets identifies Access Vascular as an emerging leader in the vascular access device market. Its focus on next-generation catheter materials aligns with the industry’s increasing emphasis on longer dwell times, infection prevention, and improved patient safety. 

16. Argon Medical Devices

Argon Medical Devices is a global medical device manufacturer specializing in products used across interventional radiology, vascular intervention, oncology, and other minimally invasive procedures.

Its vascular portfolio includes catheter-based and access technologies used by interventional specialists. The company benefits from the continued expansion of minimally invasive procedures and demand for specialized access devices.

Argon’s positioning across multiple interventional applications provides opportunities to leverage its catheter expertise across vascular and diagnostic procedures.

17. Pakumed Medical Products GmbH

Pakumed Medical Products GmbH participates in the medical device industry with a focus on specialized products and technologies used in healthcare applications.

Its inclusion among the companies covered in the vascular access device market reflects the presence of specialized European manufacturers serving focused medical-device segments.

The company represents the broader ecosystem of specialized suppliers contributing to product diversity and regional competition in vascular access technologies.

18. Guangdong Baihe Medical Technology Co., Ltd.

Guangdong Baihe Medical Technology is a China-based medical device manufacturer participating in the expanding vascular access market.

The company’s presence is particularly relevant as China’s domestic medical device industry continues to expand and healthcare providers increasingly adopt locally manufactured technologies.

MarketsandMarkets identifies Guangdong Baihe Medical Technology as an emerging participant in the vascular access device market. Its growth reflects the broader expansion of Asian manufacturers and the increasing demand for cost-effective catheter technologies across developing healthcare systems. 

19. PFM Medical GmbH

PFM Medical GmbH is a Germany-based medical technology company participating in specialized healthcare device markets.

Its inclusion in the vascular access competitive landscape highlights the role of specialized European companies alongside larger multinational manufacturers.

The company’s presence contributes to the diversity of suppliers serving vascular access and related clinical applications, particularly within European healthcare markets.

20. Medi-Tech Devices Pvt. Ltd.

Medi-Tech Devices is an India-based medical device company participating in the growing vascular access market.

India represents an important growth opportunity for vascular access manufacturers because of its expanding hospital infrastructure, increasing healthcare expenditure, growing chronic disease burden, and rising demand for cost-effective medical technologies.

MarketsandMarkets identifies Medi-Tech Devices among emerging companies in the vascular access market. Its position reflects the increasing participation of Indian manufacturers in global medical-device supply chains. 

21. Kimal

Kimal is a medical technology company with expertise in vascular access and related catheter-based healthcare products.

The company serves specialized clinical applications and contributes to the European vascular access ecosystem. Its participation demonstrates the continued importance of specialized catheter manufacturers in a market increasingly focused on safety, performance, and procedure-specific solutions.

As healthcare providers seek products tailored to particular clinical workflows, specialized companies such as Kimal can address targeted opportunities within the wider market.

22. Poly Medicure

Poly Medicure, commonly known as Polymed, is an India-based medical device manufacturer with a broad portfolio of disposable medical products.

The company’s capabilities include catheter and infusion-related products used across hospital and clinical applications. Its manufacturing scale and presence in international markets position it to benefit from growing demand for affordable, single-use medical devices.

Poly Medicure is particularly relevant to emerging markets, where healthcare providers increasingly require reliable vascular access technologies at competitive costs.

23. Delta Med

Delta Med is an Italy-based medical device manufacturer participating in the vascular access and catheter market.

The company represents the specialized European manufacturing segment, with capabilities focused on medical devices and catheter-based applications.

MarketsandMarkets identifies Delta Med as an emerging player in the vascular access market. Its position reflects opportunities for focused manufacturers that develop differentiated catheter designs and serve specific clinical applications. 

24. Newtech Medical Devices Pvt. Ltd.

Newtech Medical Devices is an India-based medical device company participating in the country’s expanding medical technology ecosystem.

The company’s inclusion in the vascular access market reflects the increasing role of domestic manufacturers in supplying catheter and disposable medical technologies.

India’s growing healthcare infrastructure, expanding hospital networks, and increasing demand for cost-effective devices create opportunities for companies such as Newtech Medical Devices to strengthen their market presence.

25. Shanghai Puyi Medical Instruments Co., Ltd.

Shanghai Puyi Medical Instruments is a China-based medical device company participating in the vascular access ecosystem.

Its presence reflects China’s expanding domestic medical-device manufacturing base and the growing demand for vascular access technologies across hospitals and healthcare institutions.

As healthcare investment and medical-device adoption continue to expand across Asia Pacific, Chinese manufacturers are expected to play an increasingly important role in supplying vascular access products to both domestic and international markets.